Delivery Order SPE2DB25D3504-SPE2DB25FVWEK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Eliquis 5 mg tablets (60-count units) at a firm fixed price ceiling value of $25,069.77. This non-set-aside, competitively awarded contract is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract with a ceiling value of $40,757.83. This non-set-aside award represents a competitive procurement action and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. The delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $67,560.58. This firm fixed-price delivery order, with an ultimate completion date of September 3, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a contract value of $4,313.92. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $3,484.49. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026. The delivery order carries an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $24,530.35. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, carries no set-aside designation and was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $36,722.05. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 22, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60-tablet packages. This firm fixed-price delivery order, valued at $39,593.14, is a non-set-aside award issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive...
- The Defense Logistics Agency awarded a $45,093.16 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 2, 2025. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVWEKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $4,604.54. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of September 3, 2025. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026 that authorizes the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's pharmaceutical supply portfolio under the DLA contract encompasses brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. AmerisourceBergen's demonstrated capability to meet federal procurement requirements through open competition, combined with its significant contract values and global reach, positions it as a key supplier supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and comprehensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/2/25 |